The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications.
| Autor: | Rodríguez Barrios JM; Medtronic Iberica, Madrid, Spain., Pérez Alcántara F, Crespo Palomo C, González García P, Antón De Las Heras E, Brosa Riestra M |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2012 Dec; Vol. 13 (6), pp. 723-40. Date of Electronic Publication: 2011 Jun 10. |
| DOI: | 10.1007/s10198-011-0326-y |
| Abstrakt: | Objectives: The objective of this study was to evaluate the methodological characteristics of cost-effectiveness evaluations carried out in Spain, since 1990, which include LYG as an outcome to measure the incremental cost-effectiveness ratio. Methods: A systematic review of published studies was conducted describing their characteristics and methodological quality. We analyse the cost per LYG results in relation with a commonly accepted Spanish cost-effectiveness threshold and the possible relation with the cost per quality adjusted life year (QALY) gained when they both were calculated for the same economic evaluation. Results: A total of 62 economic evaluations fulfilled the selection criteria, 24 of them including the cost per QALY gained result as well. The methodological quality of the studies was good (55%) or very good (26%). A total of 124 cost per LYG results were obtained with a mean ratio of 49,529 Conclusions: There is an increasing interest for economic health care evaluations in Spain, and the quality of the studies is also improving. Although a commonly accepted threshold exists, further information is needed for decision-making as well as to identify the relationship between the costs per LYG and per QALY gained. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink